News | March 18, 2008

I-Flow Will Purchase Infection Control Product Maker AcryMed

March 19, 2008 - I-Flow Corp. recently entered into a binding letter of intent to acquire AcryMed Inc., a privately held Oregon-based developer of infection control and wound healing products, for $25 million in cash.

The company said it hopes to take advantage of the long-term growth opportunity for its ON-Q SilverSoaker Catheters potentially large infection control market.

"With the acquisition of AcryMed, which closed on Feb. 15, 2008, I-Flow now owns the proprietary nanoparticle treatment technology that has already proven itself in our ON-Q PainBuster with ON-Q SilverSoaker Antimicrobial Catheter, the only pain relief pump to document an infection reduction capability," said Donald M. Earhart, I-Flow's chairman and CEO. "This innovative technology will also be featured in a new line of silver transparent wound-site dressings AcryMed will manufacture for I-Flow, which we plan to bring to market this year. We see additional new product opportunities on the horizon."

AcryMed also is active in researching and developing new wound care technologies and has licensed a portion of these technologies for a range of infection control and wound care products.

Under the acquisition Bruce Gibbins, AcryMed's founder, chief technology officer and chairman, and Jack McMaken, AcryMed's CEO and president, will join I-Flow under new, full-time employment agreements.

A major research study reported at last year's 47th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) concluded that I-Flow's ON-Q Painbuster and ON-Q SilverSoaker catheter, delivering a local anesthetic to treat the pain, is responsible for reducing surgical site infection rates following colorectal surgeries by more than 50 percent and shortening hospital stays by more than two days when compared with traditional narcotic pain care.

"These findings are especially significant in view of the recent announcement by the Centers for Medicare and Medicaid Services (CMS) that, for discharges occurring on or after Oct. 1, 2008, hospitals will not receive additional payment for patients in whom certain conditions were not present on admission, such as hospital-acquired infections," Earhart said

To help expand the addressable market, I-Flow said it initiated a new study to assess the impact of using ON-Q on the incidence of pneumonia and infections in patients undergoing heart surgery. The company has also developed a new professional promotional campaign that combines the ON-Q pain relief message with information on the infection study results and additional data establishing the relevancy of infections in the hospital setting.

I-Flow announced March 17 it saw a 32 percent increase in its regional anesthesia business in 2007, to a record $89.6 million compared to $67.9 million for 2006. Regional anesthesia sales increased 29 percent for the fourth quarter of 2007. Those sales included the ON-Q PainBuster Post-Operative Pain Relief System, and the ON-Q SilverSoaker Catheter.

For more information:

Related Content

Henry Ford Hospital's ViewRay MRIdian linear accelerator system allows real-time MRI-guided radiotherapy. Shown is the support staff for this system. In the center of the photo is Benjamin Movsas, M.D., chair of radiation oncology at Henry Ford Cancer Institute. Second from the right is Carrie Glide-Hurst, Ph.D., director of translational research, radiation oncology.

Henry Ford Hospital's ViewRay MRIdian linear accelerator system allows real-time MRI-guided radiotherapy. Shown is the support staff for this system. In the center of the photo is Benjamin Movsas, M.D., chair of radiation oncology at Henry Ford Cancer Institute. Second from the right is Carrie Glide-Hurst, Ph.D., director of translational research, radiation oncology.

Feature | Henry Ford Hospital | May 21, 2019 | Dave Fornell, Editor
Henry Ford Hospital thought leaders regularly speak at the radiation oncology and radiology conferences about new res
Philips Launches IntraSight Interventional Applications Platform
Technology | Interventional Radiology | May 20, 2019
Philips announced the launch of the new IntraSight interventional applications platform. The secure, application-based...
Netherlands Hospital to Install State-of-the-Art MRI Ablation Center
News | Magnetic Resonance Imaging (MRI) | May 13, 2019
Imricor announced the signing of a commercial agreement with the Haga Hospital in The Hague, Netherlands to outfit a...
Clinical Trial Explores Opening Blood-Brain Barrier in Fight Against Alzheimer's

Vibhor Krishna, M.D., (right) fits David Shorr with a helmet-like device used in a new clinical trial for Alzheimer’s disease at The Ohio State University Wexner Medical Center. The device uses MRI-guided imaging to deliver focused ultrasound to specific areas of the brain to open the blood-brain barrier. Image courtesy of Ohio State University Wexner Medical Center.

News | Focused Ultrasound Therapy | May 09, 2019
May 9, 2019 — A new clinical trial at The Ohio State University Wexner Medical Center and two other sites is testing
Ultrasonic Device Safe and Effective for Lung Vessel Sealing in Minimally Invasive Lobectomy
News | Interventional Radiology | May 06, 2019
According to a new study, an ultrasonic vessel-sealing device can improve patient outcomes by reducing the incidence of...
360 degree view inside an Interventional radiology lab at Henry Ford Hospital used for neuro-interventions and stroke.
360 Photos | 360 View Photos | May 06, 2019
This is a 360 degree photo view inside the neuro-interventional radiology lab at ...
Multisociety Position Statement Endorses Prostatic Artery Embolization
News | Interventional Radiology | May 02, 2019
A new position statement from interventional radiology professional societies in the U.S. and Europe states that...
Mentice and RAD-AID Collaborate to Improve Access to Interventional Radiology in Resource-constrained Regions
News | Interventional Radiology | April 22, 2019
April 22, 2019 — Mentice AB, provider of endovascular performance solutions, has signed an agreement with the nonprof
Ethicon Launches Global Liver Lesion Ablation Registry
News | Interventional Radiology | April 10, 2019
Johnson & Johnson Medical Devices Companies announced Ethicon has launched a new global registry to collect and...